CLINICAL_TRIALS ClinicalTrials.gov record update

Phase II Trial of Lenvatinib in Metastatic or Advanced Pheochromocytoma and Paraganglioma

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT03008369
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:39:57.596367+00:00
Published At: 2021-05-14T00:00:00+00:00
Record Updated At: 2024-02-20
Results Posted At: 2021-05-14
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Malignant Adrenal Gland Pheochromocytoma", "Malignant Paraganglioma", "Metastatic Adrenal Gland Pheochromocytoma"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2024-02-20"
protocolSection.identificationModule.nctId: "NCT03008369"
protocolSection.identificationModule.officialTitle: "Phase II Trial of Lenvatinib in Metastatic or Advanced Pheochromocytoma and Paraganglioma"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2021-05-14"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.